Atlas.
Sign inStart free trial
MEDPNASDAQ · US

Medpace Holdings, Inc.

Technology · Services-Commercial Physical & Biological Research

TechnologyServices-Commercial Physical & Biological Research
CEO
August Troendle, MD
Founded
—
IPO Date
—
HQ
Cincinnati, OH, United States
Exchange
NASDAQ
Employees
n.a.

Share Price Performance

$543.57 ▼ 4.8%
Last (1 Jul 2026) · $544
Period High · $620.59
Period Low · $0.00
52W: $543.57 – $620.59

Key Metrics

Share Price
$543.57
+2.6% today
Market Cap
$15.3B
P / E
33.9x
EV / Revenue
5.9x
Revenue Growth
+20.0%
year-on-year
Gross Margin
—
Enterprise Value
$14.8B
52W High
$620.59
52W Low
$0.00
Avg Volume
371K
daily

Sources: SEC filings · Market data as of Jul 6, 2026

Shareholders' Structure
13 known institutional holders·$3.0B total on record·2026-Q1
BlackRock, Inc.
8.8%·$1.2B
Geode Capital Management, LLC
2.6%·$358M
State Street Corp
2.4%·$328M
Invesco Ltd.
2.1%·$277M
Renaissance Technologies LLC
1.8%·$242M
Dimensional Fund Advisors LP
1.2%·$167M
Price T Rowe Associates Inc
1.0%·$139,020
Northern Trust Corp
0.8%·$109M
Bank Of America Corp
0.8%·$102M
Goldman Sachs Group Inc
0.6%·$81M
Fmr LLC
0.6%·$77M
Jpmorgan Chase & Co
0.5%·$71M
Worldquant Millennium Advisors LLC
0.0%·$1M
Free Float
76.8%

Sources: SEC filings

Notes: % shown as share of total shares outstanding · Free float = shares outstanding minus all known 13F institutional holdings

What Atlas covers for Medpace Holdings, Inc.
OverviewMedpace Holdings, Inc. share price history (10 years), key market statistics, and institutional shareholder structure from SEC 13F-HR filings.Business ModelHow Medpace Holdings, Inc. generates revenue — product and service segments, geographic breakdown, key operating metrics, and 10-year business evolution sourced from SEC filings.FinancialsMedpace Holdings, Inc.'s complete financial history — 10 years of annual revenue, gross margins, operating income, net income, EPS, and free cash flow from SEC filings, plus 12 quarters of quarterly results.Management QualityMedpace Holdings, Inc. executive team profiles, insider buying and selling from SEC Form 4, earnings call transcripts, and a track record of guidance delivery vs actual results.Risk FactorsMedpace Holdings, Inc.'s annual risk disclosures from SEC filings — full text, 5-year evolution showing how risks have shifted, and year-on-year delta highlighting new and removed risks.NewsAI-synthesised news digest for Medpace Holdings, Inc., updated regularly with key developments, earnings updates, product announcements, and material company events.SentimentInvestor sentiment for Medpace Holdings, Inc. aggregated from X.com, Reddit, and Hacker News — discussion themes, Bull and Bear signals, and community analysis.Valuation & PeersMedpace Holdings, Inc. valuation multiples — P/E, EV/Revenue, EV/EBITDA — compared against a curated set of industry peers using live data from SEC filings. Custom peer selection available.DCF BuilderBuild a discounted cash flow model for Medpace Holdings, Inc. with 10 years of pre-filled revenue, margins, and cash flow data from SEC filings. Adjust growth rates, WACC, and terminal assumptions.Atlas AnalysisAtlas AI research synthesis for Medpace Holdings, Inc. — business model, financial health, management quality, risk profile, and institutional ownership, grounded exclusively in SEC filings.

Unlock the full analysis

9-tab institutional research sourced directly from SEC filings. No tips, no scores — the same process professional investors use.

7-day free trial · Plus & Pro · No charge during trial